JM Boiron

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

Emmanuelle Tavernier, JM Boiron, Françoise Huguet et al. · Leukemia · 2007 · 254 citations

Hematological Malignancy, Lymphoid Neoplasia, Lala-94 Trial +10

A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients

Olivier Fitoussi, Virginie Perreau, JM Boiron et al. · Bone Marrow Transplantation · 2001 · 88 citations

Hematological Malignancy, Oncology, Medicine +12

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

Hélène Espérou, JM Boiron, JM Cayuela et al. · Bone Marrow Transplantation · 2003 · 63 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +8

Peripheral Blood Progenitor Cell Transplantation in 118 Patients with Hematological Malignancies: Analysis of Factors Affecting the Rate of Engraftment

Josy Reiffers, C. Fabères, JM Boiron et al. · Journal of Hematotherapy · 1994 · 49 citations

Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome

Marie‐Thérèse Rubio, Nathalie Dhédin, Claude Boucheix et al. · British Journal of Haematology · 2003 · 36 citations